Hypotension after General Anesthesia Induction with Remimazolam or Propofol in Geriatric Patients Undergoing Sevoflurane Anesthesia with Remifentanil

作者
Dr. Aman Bharti,Keshav Dev Jagar,Shailja Sharma,Dr. Nikhil Sharma,Bijal Bhati
出处
期刊:International Journal of Medical and All Body Health Research [Anfo Publication House]
卷期号:6 (3): 186-192
标识
DOI:10.54660/ijmbhr.2025.6.3.186-192
摘要

Hemodynamic instability, particularly hypotension, remains a significant concern during anesthesia induction in geriatric patients. This study compared the incidence and severity of post-induction hypotension between remimazolam and propofol in elderly patients undergoing sevoflurane-based general anesthesia with remifentanil. A prospective, randomized, double-blind study was conducted involving 180 patients aged ≥65 years scheduled for elective surgery under general anesthesia. Patients were randomly allocated to receive either remimazolam (0.3 mg/kg) or propofol (1.5 mg/kg) for anesthesia induction, followed by sevoflurane maintenance with remifentanil infusion. Primary outcome was the incidence of hypotension (systolic blood pressure <90 mmHg or >30% decrease from baseline) within 10 minutes post-induction. Secondary outcomes included hemodynamic parameters, vasopressor requirements, and adverse events. The incidence of post-induction hypotension was significantly lower in the remimazolam group compared to the propofol group (32.2% vs 57.8%, p<0.001). Mean arterial pressure decreased by 18.5±8.2% in the remimazolam group versus 28.7±11.4% in the propofol group (p<0.001). Vasopressor requirement was reduced by 40% in the remimazolam group. Time to loss of consciousness was comparable between groups (98±23 s vs 94±21 s, p=0.312). Remimazolam demonstrated superior hemodynamic stability compared to propofol during anesthesia induction in geriatric patients, with significantly reduced incidence of hypotension and vasopressor requirements while maintaining comparable efficacy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
与可完成签到,获得积分10
刚刚
尊敬寒松完成签到 ,获得积分10
刚刚
如初完成签到,获得积分10
刚刚
轩扬完成签到,获得积分10
1秒前
顺利翠萱完成签到,获得积分10
1秒前
1秒前
材料k完成签到,获得积分10
1秒前
天天向上的应助被梁潇鸿采纳,获得10
1秒前
1秒前
solar@2030发布了新的文献求助10
2秒前
ypljk完成签到,获得积分10
2秒前
背后迎夏完成签到 ,获得积分10
2秒前
Farrell完成签到 ,获得积分10
3秒前
听话的寒天完成签到,获得积分10
3秒前
山野村夫完成签到,获得积分10
4秒前
乐观健柏完成签到,获得积分0
4秒前
蓝林完成签到,获得积分10
5秒前
小苹果完成签到,获得积分0
5秒前
奋斗小真完成签到 ,获得积分10
5秒前
zhs完成签到,获得积分10
5秒前
故里完成签到,获得积分10
5秒前
小胡完成签到,获得积分10
5秒前
吴锋完成签到,获得积分10
6秒前
菠萝汁完成签到,获得积分10
7秒前
fantasy的应助被今晨依然动馨采纳,获得10
7秒前
hahabaozi完成签到 ,获得积分10
7秒前
纯真的夏兰完成签到,获得积分10
7秒前
临河盗龙完成签到,获得积分10
7秒前
孤星完成签到,获得积分10
7秒前
白色大鸟发布了新的文献求助10
7秒前
FashionBoy的应助被古月水兽采纳,获得10
7秒前
水煮电吹风的应助被陌路孤星采纳,获得10
7秒前
昭蘅完成签到 ,获得积分10
8秒前
eagle14835完成签到,获得积分10
8秒前
有生之年完成签到,获得积分10
8秒前
勤劳锦程完成签到 ,获得积分10
8秒前
messyknots完成签到,获得积分10
9秒前
9秒前
寡王一路硕博完成签到,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039